Structure-centered design of lipid-based nanocarriers to overcome biological barriers
Materials Today Bio · 2025-12 · 35 · 102425
DOI: 10.1016/j.mtbio.2025.102425 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Materials Today Bio, 2025-12. Verfasst von Yeeun Woo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Kwangwoon University, 20 Gwangwoon-Ro, Nowon-Gu, Seoul, 01897, Republic of Korea. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea, National Research Foundation of Korea, Ministry of Trade, Industry and Energy.
Abstract (Originalsprache)
As technology has evolved in response to pressing human challenges, drug delivery systems (DDSs) have also evolved to overcome complex biological barriers. Particularly, the continuous development of therapeutic strategies has enabled the integration of nanotechnology, leading to the emergence of diverse nanoscale DDSs. Concerns about the potential toxicity of nanomedicines diverted attention to lipid-based nanocarriers (LBNs), regarded as safer and more biocompatible platforms. In this review, the structural evolution of LBNs is categorized into three stages according to the increasing functional complexity required to address biological barriers, providing a framework to understand how designs advanced with physiological demands. This trajectory encompasses emulsions and LBNs, with each stage advanced by strategies such as lipid composition tuning, surface functionalization, biomimetic construction, and hybridization with other platforms. Over a few decades, this transition has described that the progression of LBNs reflects not merely chronological advances but a stepwise evolution of structural adaptations shaped by biological barriers. This analytical perspective is presented through a comprehensive discussion of the structural strategies utilized in recent LBN research. Consequently, structural evolution provides a foundation for refining design approaches in drug delivery and achieving improved therapeutic outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical Engineering, Kwangwoon University, 20 Gwangwoon-Ro, Nowon-Gu, Seoul, 01897, Republic of Korea.
- Department of Biotechnology, Sangmyung University, 20, Hongjimun 2-gil, Seoul, 03016, Republic of Korea.
- School of Integrative Engineering, Chung-Ang University, Heukseok-dong, Dongjak-gu, Seoul, 06910, Republic of Korea.
Förderung
- Ministry of Science and ICT, South Korea
- National Research Foundation of Korea
- Ministry of Trade, Industry and Energy
Zitieren
APA
Woo, Y., Yoon, J., Seo, Y., Han, Y., Yoo, H. Y., Sohn, H., Lee, M. H., & Lee, T. (2025). Structure-centered design of lipid-based nanocarriers to overcome biological barriers. Materials Today Bio, 35, 102425. https://doi.org/10.1016/j.mtbio.2025.102425
Vancouver
Woo Y, Yoon J, Seo Y, Han Y, Yoo HY, Sohn H, et al. Structure-centered design of lipid-based nanocarriers to overcome biological barriers. Materials Today Bio. 2025;35:102425. doi:10.1016/j.mtbio.2025.102425
BibTeX
@article{Woo2025,
author = {Woo, Yeeun and Yoon, Jinwook and Seo, Yoseph and Han, Yunseon and Yoo, Hah Young and Sohn, Hiesang and Lee, Min-Ho and Lee, Taek},
title = {Structure-centered design of lipid-based nanocarriers to overcome biological barriers},
journal = {Materials Today Bio},
year = {2025},
volume = {35},
pages = {102425},
doi = {10.1016/j.mtbio.2025.102425}
}
EUVIMED